Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor.

@article{Jain2014OutcomePI,
  title={Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor.},
  author={Rajan Jain and Laila M. Poisson and David Gutman and Lisa Scarpace and Scott N. Hwang and Chad A. Holder and Max Wintermark and Arvind U. K. Rao and Rivka R. Colen and Justin Kirby and J. Freymann and Carl C. Jaffe and T. G. Mikkelsen and Adam E. Flanders},
  journal={Radiology},
  year={2014},
  volume={272 2},
  pages={484-93}
}
PURPOSE To correlate patient survival with morphologic imaging features and hemodynamic parameters obtained from the nonenhancing region (NER) of glioblastoma (GBM), along with clinical and genomic markers. MATERIALS AND METHODS An institutional review board waiver was obtained for this HIPAA-compliant retrospective study. Forty-five patients with GBM underwent baseline imaging with contrast material-enhanced magnetic resonance (MR) imaging and dynamic susceptibility contrast-enhanced T2… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 47 extracted citations

Similar Papers

Loading similar papers…